No black box warning on record for Clonidine Transdermal System Usp, 0.1 Mg/day

As of the latest FDA labeling reviewed, Clonidine Transdermal System Usp, 0.1 Mg/day (CLONIDINE TRANSDERMAL SYSTEM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clonidine Transdermal System Usp, 0.1 Mg/day medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Withdrawal Patients should be instructed not to discontinue therapy without consulting their physician. Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, tremor, and confusion accompanied or followed by a rapid rise in blood pressure and elevated catecholamine concentrations in the plasma. The likelihood of such reac

No black box warning on record for Clonidine Transdermal System Usp, 0.1 Mg/day

Other warnings & precautions

WARNINGS Withdrawal Patients should be instructed not to discontinue therapy without consulting their physician. Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, tremor, and confusion accompanied or followed by a rapid rise in blood pressure and elevated catecholamine concentrations in the plasma. The likelihood of such reac

Clonidine Transdermal System Usp, 0.1 Mg/day Black Box Warning

No black box warning on record for Clonidine Transdermal System Usp, 0.1 Mg/day

Other warnings & precautions

Clonidine Transdermal System Usp, 0.1 Mg/day Black Box Warning

No black box warning on record for Clonidine Transdermal System Usp, 0.1 Mg/day

Other warnings & precautions